Mee Sook Park

Dr. Mee Sook Park


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
JBJoon-Yong Bae
Joon-Yong Bae
JKJin Il Kim
Jin Il Kim
MPMee Sook Park
Mee Sook Park
GLGee Eun Lee
Gee Eun Lee
HPHeedo Park
Heedo Park
MPMan-Seong Park
Man-Seong Park
Zoonotic transmission of orthohantaviruses from rodent reservoirs to humans has been the cause of severe fatalities. Human infections are reported worldwide, but vaccines have been approved only in China and Korea. Orthohantavirus vaccine development has been pursued with no sense of urgency due to the relative paucity of cases in countries outside China and Korea. However, the orthohantaviruses continuously evolve in hosts and thus the current vaccine may not work as well against some variants. Therefore, a more effective vaccine should be prepared against the orthohantaviruses. In this review, we discuss the issues caused by the orthohantavirus vaccine. Given the pros and cons of the orthohantavirus vaccine, we suggest strategies for the development of better vaccines in terms of pandemic preparedness.